Analyst Viewpoint
Rise in prevalence of infertility is fueling the global assisted reproductive technology market expansion. A delay in maternal age coupled with chronic stress and unhealthy coping habits leads to an increase in cases of couples struggling to get pregnant. IVF and egg or embryo banks are popular assisted reproductive services augmenting market demand.
Prominent players operating in the global assisted reproductive technology industry are adopting artificial intelligence and investing heavily in innovative technologies that make fertility care more affordable and accessible. Governments in various countries are prompting healthcare insurers to integrate infertility treatment procedures into their plans.
Assisted Reproductive Technology (ART)is a medical procedure that assists in fertility issues or an inability to conceive children. ART treatments involve the manipulation of eggs, sperm, or embryos to enhance the chances of conception and the likelihood of a successful and safe pregnancy. The procedure is highly invasive, expensive, and time-consuming. Male infertility treatment options include surgery, hormone therapy, artificial insemination, and intracytoplasmic sperm injection.
In vitro fertilization or IVF is the most common ART procedure and involves fertilizing an egg with a sperm outside the body in a laboratory environment and then transferring the formed embryo to the uterus. The success of ART depends on several factors such as age, type of procedure, and extent or cause of infertility. R&D in ART and surge in cases of infertility are driving the market statistics.
Delay in maternal age, several environmental reasons, and an unhealthy lifestyle are key factors leading to the rise in the prevalence of infertility worldwide. Chronic stress, decreased attention to personal hygiene, and long working hours can affect sperm production and testosterone levels in men and affect ovulation cycles in women. As per the World Health Organization (WHO), an estimated 1 in 6 reproductive adults globally experience infertility in their lifetime.
According to a report by Inito, a Bengaluru-based medical technology company, over 27.5 million couples in India are struggling to conceive a child. This accounts for about 10-15% of total married couples in India. Medical research also shows that over 90% of infertility cases can be treated with drugs, surgery, and reproductive technologies such as IVF and artificial insemination. Surge in awareness about these treatment procedures and drugs is boosting the assisted reproductive technology market development.
Advancements in fertility treatments range from drug options and surgeries to complex technological alternatives such as egg or embryo storage and artificial insemination. According to a report published in the National Center for Biotechnology Information, IVF success rates have stayed stagnant for years at 30% and researchers believe utilization of Artificial Intelligence (AI) can improve these numbers.
Adoption of AI in clinics can assist the practitioner in assessing embryo and gamete health with more accuracy and objectivity based on image classification. AI can also aid doctors to create a personalized treatment plan for couples. AI-enabled image-processing systems can help select embryos with the best implantation potential. Hence, integration of AI in fertility treatments is expected to spur the assisted reproductive technology market growth in the near future.
Pre-implantation genetic screening is a sophisticated system used to screen embryos for specific genetic conditions. It increases the probability of a successful and safe pregnancy. Innovation in cryopreservation of eggs, sperms, and embryos offers couples and individuals flexibility over their bodies and reproductive options.
According to a recent assisted reproductive technology market analysis, North America had largest share in 2022. Presence of a well-developed healthcare sector, rise in awareness about reproductive assistance, and R&D of reproductive medicines and solutions are augmenting the market dynamics of the region. As per the U.S Census Bureau, over the past three decades, women’s fertility in the age group 20 to 23 has decreased by 43.0% while first-time motherhood has risen by 67.0% in the age group of 35 to 39 years.
According to the latest assisted reproductive technology market forecast, the industry in Asia Pacific is expected to grow at a steady pace from 2023 to 2031. Surge in prevalence of infertility and changes in lifestyle among the young population are driving the market landscape in the region.
As per a national survey conducted in Japan in 2021, over 10% of all couples in the country suffer from infertility. The survey also pointed out that IVF has grown in popularity in Japan and the government plans to integrate the process and other fertility treatments into the national insurance policy.
According to recent assisted reproductive technology market trends, prominent manufacturers are investing heavily in the development of infertility intervention technologies. They are developing advanced fertility treatments for assisted conception and affordable egg donation processes for consumers. These activities are likely to increase their assisted reproductive technology industry share during the forecast period.
Merck KGaA, CooperSurgical, Inc., FUJIFILM Irvine Scientific., Vitrolife AB, Hamilton Thorne, Inc., Nikon Corporation, Nidacon International AB, Laboratoire CCD, and Esco Micro Pte. Ltd. are key firms operating in this market.
These companies have been profiled in the assisted reproductive technology market report based on various parameters such as company overview, business strategies, product portfolio, financial overview, and business segments.
| Attribute | Detail |
|---|---|
| Market Value in 2022 (Base Year) | US$ 25.9 Bn |
| Market Forecast Value in 2031 | US$ 58.6 Bn |
| Growth Rate (CAGR) | 9.4% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | Qualitative analysis includes drivers, restraints, opportunities, key trends, key market indicators, Porter’s Five Forces analysis, value chain analysis, and SWOT analysis. Furthermore, at the regional level, the qualitative analysis includes key trends, price trends, and key supplier analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Regions Covered |
|
| Countries Covered |
|
| Market Segmentation |
|
| Companies Profiled |
|
| Customization Scope | Available upon Request |
| Pricing | Available upon Request |
It was valued at US$ 25.9 Bn in 2022
It is projected to grow at a CAGR of 9.4% from 2023 to 2031
Rise in prevalence of infertility and R&D in fertility treatment
The in vitro fertilization technology segment held the largest share in 2022
North America was the leading region in 2022
Merck KGaA, CooperSurgical, Inc., FUJIFILM Irvine Scientific., Vitrolife AB, Hamilton Thorne, Inc., Nikon Corporation, Nidacon International AB, Laboratoire CCD, and Esco Micro Pte. Ltd.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Assisted Reproductive Technology Market
4. Market Overview
4.1. Introduction
4.1.1. Technology Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Assisted Reproductive Technology Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Technology/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Assisted Reproductive Technology Market Analysis and Forecast, by Technology
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Technology, 2017–2031
6.3.1. In Vitro Fertilization
6.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
6.3.1.2. Preimplantation Genetic Diagnosis (PGD)
6.3.2. Artificial Insemination
6.3.2.1. Intrauterine Insemination (IUI)
6.3.2.2. Intracervical Insemination (ICI)
6.3.2.3. Others
6.3.3. Surrogacy
6.3.4. Others
6.4. Market Attractiveness Analysis, by Technology
7. Global Assisted Reproductive Technology Market Analysis and Forecast, by Procedure
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Procedure, 2017–2031
7.3.1. Frozen Donor
7.3.2. Frozen Non-donor
7.3.3. Fresh Donor
7.3.4. Fresh Non-donor
7.3.5. Embryo Banking
7.4. Market Attractiveness Analysis, by Procedure
8. Global Assisted Reproductive Technology Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Fertility Clinics
8.3.2. Hospitals
8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Assisted Reproductive Technology Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017–2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Assisted Reproductive Technology Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Technology, 2017–2031
10.3.1. In Vitro Fertilization
10.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
10.3.1.2. Preimplantation Genetic Diagnosis (PGD)
10.3.2. Artificial Insemination
10.3.2.1. Intrauterine Insemination (IUI)
10.3.2.2. Intracervical Insemination (ICI)
10.3.2.3. Others
10.3.3. Surrogacy
10.3.4. Others
10.4. Market Value Forecast, by Procedure, 2017–2031
10.4.1. Frozen Donor
10.4.2. Frozen Non-donor
10.4.3. Fresh Donor
10.4.4. Fresh Non-donor
10.4.5. Embryo Banking
10.5. Market Value Forecast, by End-user, 2017–2031
10.5.1. Fertility Clinics
10.5.2. Hospitals
10.5.3. Others
10.6. Market Value Forecast, by Country, 2017–2031
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Technology
10.7.2. By Procedure
10.7.3. By End-user
10.7.4. By Country
11. Europe Assisted Reproductive Technology Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Technology, 2017–2031
11.3.1. In Vitro Fertilization
11.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
11.3.1.2. Preimplantation Genetic Diagnosis (PGD)
11.3.2. Artificial Insemination
11.3.2.1. Intrauterine Insemination (IUI)
11.3.2.2. Intracervical Insemination (ICI)
11.3.2.3. Others
11.3.3. Surrogacy
11.3.4. Others
11.4. Market Value Forecast, by Procedure, 2017–2031
11.4.1. Frozen Donor
11.4.2. Frozen Non-donor
11.4.3. Fresh Donor
11.4.4. Fresh Non-donor
11.4.5. Embryo Banking
11.5. Market Value Forecast, by End-user, 2017–2031
11.5.1. Fertility Clinics
11.5.2. Hospitals
11.5.3. Others
11.6. Market Value Forecast, by Country/Sub-region, 2017–2031
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Technology
11.7.2. By Procedure
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific Assisted Reproductive Technology Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Technology, 2017–2031
12.3.1. In Vitro Fertilization
12.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
12.3.1.2. Preimplantation Genetic Diagnosis (PGD)
12.3.2. Artificial Insemination
12.3.2.1. Intrauterine Insemination (IUI)
12.3.2.2. Intracervical Insemination (ICI)
12.3.2.3. Others
12.3.3. Surrogacy
12.3.4. Others
12.4. Market Value Forecast, by Procedure, 2017–2031
12.4.1. Frozen Donor
12.4.2. Frozen Non-donor
12.4.3. Fresh Donor
12.4.4. Fresh Non-donor
12.4.5. Embryo Banking
12.5. Market Value Forecast, by End-user, 2017–2031
12.5.1. Fertility Clinics
12.5.2. Hospitals
12.5.3. Others
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Technology
12.7.2. By Procedure
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America Assisted Reproductive Technology Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Technology, 2017–2031
13.3.1. In Vitro Fertilization
13.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
13.3.1.2. Preimplantation Genetic Diagnosis (PGD)
13.3.2. Artificial Insemination
13.3.2.1. Intrauterine Insemination (IUI)
13.3.2.2. Intracervical Insemination (ICI)
13.3.2.3. Others
13.3.3. Surrogacy
13.3.4. Others
13.4. Market Value Forecast, by Procedure, 2017–2031
13.4.1. Frozen Donor
13.4.2. Frozen Non-donor
13.4.3. Fresh Donor
13.4.4. Fresh Non-donor
13.4.5. Embryo Banking
13.5. Market Value Forecast, by End-user, 2017–2031
13.5.1. Fertility Clinics
13.5.2. Hospitals
13.5.3. Others
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Technology
13.7.2. By Procedure
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa Assisted Reproductive Technology Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Technology, 2017–2031
14.3.1. In Vitro Fertilization
14.3.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
14.3.1.2. Preimplantation Genetic Diagnosis (PGD)
14.3.2. Artificial Insemination
14.3.2.1. Intrauterine Insemination (IUI)
14.3.2.2. Intracervical Insemination (ICI)
14.3.2.3. Others
14.3.3. Surrogacy
14.3.4. Others
14.4. Market Value Forecast, by Procedure, 2017–2031
14.4.1. Frozen Donor
14.4.2. Frozen Non-donor
14.4.3. Fresh Donor
14.4.4. Fresh Non-donor
14.4.5. Embryo Banking
14.5. Market Value Forecast, by End-user, 2017–2031
14.5.1. Fertility Clinics
14.5.2. Hospitals
14.5.3. Others
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Technology
14.7.2. By Procedure
14.7.3. By End-user
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. Merck KGaA
15.3.1.1. Company Overview
15.3.1.2. Technology Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. CooperSurgical, Inc.
15.3.2.1. Company Overview
15.3.2.2. Technology Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. FUJIFILM Irvine Scientific
15.3.3.1. Company Overview
15.3.3.2. Technology Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Vitrolife AB
15.3.4.1. Company Overview
15.3.4.2. Technology Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Hamilton Thorne, Inc.
15.3.5.1. Company Overview
15.3.5.2. Technology Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Nikon Corporation
15.3.6.1. Company Overview
15.3.6.2. Technology Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Nidacon International AB
15.3.7.1. Company Overview
15.3.7.2. Technology Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Laboratoire CCD
15.3.8.1. Company Overview
15.3.8.2. Technology Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Esco Micro Pte. Ltd.
15.3.9.1. Company Overview
15.3.9.2. Technology Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
List of Tables
Table 01: Global Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2017–2031
Table 02: Global Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure, 2017–2031
Table 03: Global Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 04: Global Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2017–2031
Table 07: North America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure, 2017–2031
Table 08: North America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 09: Europe Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Europe Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2017–2031
Table 11: Europe Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure, 2017–2031
Table 12: Europe Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Asia Pacific Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Asia Pacific Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2017–2031
Table 15: Asia Pacific Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure, 2017–2031
Table 16: Asia Pacific Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 17: Latin America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Latin America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2017–2031
Table 19: Latin America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure, 2017–2031
Table 20: Latin America Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Middle East & Africa Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Middle East & Africa Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Technology, 2017–2031
Table 23: Middle East & Africa Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by Procedure, 2017–2031
Table 24: Middle East & Africa Assisted Reproductive Technology Market Size (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Assisted Reproductive Technology Market Size (US$ Mn) and Distribution (%), by Region, 2017 and 2031
Figure 02: Global Assisted Reproductive Technology Market Revenue (US$ Mn), by Technology, 2022
Figure 03: Global Assisted Reproductive Technology Market Value Share, by Technology, 2022
Figure 04: Global Assisted Reproductive Technology Market Revenue (US$ Mn), by Procedure, 2022
Figure 05: Global Assisted Reproductive Technology Market Value Share, by Procedure, 2022
Figure 06: Global Assisted Reproductive Technology Market Revenue (US$ Mn), by End-user, 2022
Figure 07: Global Assisted Reproductive Technology Market Value Share, by End-user, 2022
Figure 08: Global Assisted Reproductive Technology Market Value Share, by Region, 2022
Figure 09: Global Assisted Reproductive Technology Market Value (US$ Mn) Forecast, 2023–2031
Figure 10: Global Assisted Reproductive Technology Market Value Share Analysis, by Technology, 2022 and 2031
Figure 11: Global Assisted Reproductive Technology Market Attractiveness Analysis, by Technology, 2023-2031
Figure 12: Global Assisted Reproductive Technology Market Value Share Analysis, by Procedure, 2022 and 2031
Figure 13: Global Assisted Reproductive Technology Market Attractiveness Analysis, by Procedure, 2023-2031
Figure 14: Global Assisted Reproductive Technology Market Value Share Analysis, by End-user, 2022 and 2031
Figure 15: Global Assisted Reproductive Technology Market Attractiveness Analysis, by End-user, 2022-2031
Figure 16: Global Assisted Reproductive Technology Market Value Share Analysis, by Region, 2022 and 2031
Figure 17: Global Assisted Reproductive Technology Market Attractiveness Analysis, by Region, 2022-2031
Figure 18: North America Assisted Reproductive Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 19: North America Assisted Reproductive Technology Market Attractiveness Analysis, by Country, 2023–2031
Figure 20: North America Assisted Reproductive Technology Market Value Share Analysis, by Country, 2022 and 2031
Figure 21: North America Assisted Reproductive Technology Market Value Share Analysis, by Technology, 2022 and 2031
Figure 22: North America Assisted Reproductive Technology Market Value Share Analysis, by Procedure, 2022 and 2031
Figure 23: North America Assisted Reproductive Technology Market Value Share Analysis, by End-user, 2022 and 2031
Figure 24: North America Assisted Reproductive Technology Market Attractiveness Analysis, by Technology, 2023–2031
Figure 25: North America Assisted Reproductive Technology Market Attractiveness Analysis, by Procedure, 2023–2031
Figure 26: North America Assisted Reproductive Technology Market Attractiveness Analysis, by End-user, 2023–2031
Figure 27: Europe Assisted Reproductive Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 28: Europe Assisted Reproductive Technology Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 29: Europe Assisted Reproductive Technology Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 30: Europe Assisted Reproductive Technology Market Value Share Analysis, by Technology, 2022 and 2031
Figure 31: Europe Assisted Reproductive Technology Market Value Share Analysis, by Procedure, 2022 and 2031
Figure 32: Europe Assisted Reproductive Technology Market Value Share Analysis, by End-user, 2022 and 2031
Figure 33: Europe Assisted Reproductive Technology Market Attractiveness Analysis, by Technology, 2023–2031
Figure 34: Europe Assisted Reproductive Technology Market Attractiveness Analysis, by Procedure, 2023–2031
Figure 35: Europe Assisted Reproductive Technology Market Attractiveness Analysis, by End-user, 2023–2031
Figure 36: Asia Pacific Assisted Reproductive Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 37: Asia Pacific Assisted Reproductive Technology Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 38: Asia Pacific Assisted Reproductive Technology Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 39: Asia Pacific Assisted Reproductive Technology Market Value Share Analysis, by Technology, 2022 and 2031
Figure 40: Asia Pacific Assisted Reproductive Technology Market Value Share Analysis, by Procedure, 2022 and 2031
Figure 41: Asia Pacific Assisted Reproductive Technology Market Value Share Analysis, by End-user, 2022 and 2031
Figure 42: Asia Pacific Assisted Reproductive Technology Market Attractiveness Analysis, by Technology, 2023–2031
Figure 43: Asia Pacific Assisted Reproductive Technology Market Attractiveness Analysis, by Procedure, 2023–2031
Figure 44: Asia Pacific Assisted Reproductive Technology Market Attractiveness Analysis, by End-user, 2023–2031
Figure 45: Latin America Assisted Reproductive Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 46: Latin America Assisted Reproductive Technology Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 47: Latin America Assisted Reproductive Technology Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 48: Latin America Assisted Reproductive Technology Market Value Share Analysis, by Technology, 2022 and 2031
Figure 49: Latin America Assisted Reproductive Technology Market Value Share Analysis, by Procedure, 2022 and 2031
Figure 50: Latin America Assisted Reproductive Technology Market Value Share Analysis, by End-user, 2022 and 2031
Figure 51: Latin America Assisted Reproductive Technology Market Attractiveness Analysis, by Technology, 2023–2031
Figure 52: Latin America Assisted Reproductive Technology Market Attractiveness Analysis, by Procedure, 2023–2031
Figure 53: Latin America Assisted Reproductive Technology Market Attractiveness Analysis, by End-user, 2023–2031
Figure 54: Middle East & Africa Assisted Reproductive Technology Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 55: Middle East & Africa Assisted Reproductive Technology Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 56: Middle East & Africa Assisted Reproductive Technology Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 57: Middle East & Africa Assisted Reproductive Technology Market Value Share Analysis, by Technology, 2022 and 2031
Figure 58: Middle East & Africa Assisted Reproductive Technology Market Value Share Analysis, by Procedure, 2022 and 2031
Figure 59: Middle East & Africa Assisted Reproductive Technology Market Value Share Analysis, by End-user, 2022 and 2031
Figure 60: Middle East & Africa Assisted Reproductive Technology Market Attractiveness Analysis, by Technology, 2023–2031
Figure 61: Middle East & Africa Assisted Reproductive Technology Market Attractiveness Analysis, by Procedure, 2023–2031
Figure 62: Middle East & Africa Assisted Reproductive Technology Market Attractiveness Analysis, by End-user, 2023–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Assisted Reproductive Technology Market
